No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹109.96Prev. Close
₹109.96Turnover(Lac.)
₹0.31Day's High
₹109.96Day's Low
₹104.4752 Week's High
₹131.7552 Week's Low
₹26Book Value
₹26.14Face Value
₹10Mkt Cap (₹ Cr.)
71.54P/E
36.24EPS
2.89Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 6.83 | 6.83 | 6.83 | 6.83 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1.91 | 3.47 | 3.98 | 5.23 |
Net Worth | 8.74 | 10.3 | 10.81 | 12.06 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 19.89 | 24.45 | 20.17 | 14.35 |
yoy growth (%) | -18.64 | 21.18 | 40.52 | -33.54 |
Raw materials | -14.57 | -17.79 | -10.85 | -6.73 |
As % of sales | 73.27 | 72.76 | 53.78 | 46.88 |
Employee costs | -1.49 | -1.58 | -1.81 | -1.54 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.47 | 0.96 | 0.67 | 0.26 |
Depreciation | -0.34 | -0.39 | -0.46 | -0.44 |
Tax paid | -0.16 | -0.42 | -0.1 | -0.1 |
Working capital | 0.19 | 2.02 | 0.06 | 0.41 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -18.64 | 21.18 | 40.52 | -33.54 |
Op profit growth | -107.56 | 24.37 | 397.72 | -39.1 |
EBIT growth | -50.83 | 38.23 | 162.62 | 7.53 |
Net profit growth | -42.2 | -5.76 | 252.55 | 289.14 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,807.25 | 144.46 | 4,33,619.81 | 608.7 | 0.89 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,633.05 | 66.14 | 1,76,086.64 | 756 | 0.45 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,574.95 | 69.99 | 1,54,837.1 | 467 | 0.83 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,388.8 | 32.59 | 1,12,193.56 | 384.64 | 0.94 | 3,840.92 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,104.35 | 30.09 | 1,11,123.45 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time Director
Y N Bhaskara Rao
Non Executive Director
Maneesh R Sapte
Non Executive Director
Rashmi V Sapte
Independent Director
PRAVIN M. HEGDE
Independent Director
Ajit G Jamkhandikar
Non Executive Director
Vinay Ramakant Sapte
Company Sec. & Compli. Officer
Urvashi Bhatia
16 Phase III,
I D A Jeedimetla,
Telangana - 500055
Tel: 91-40-23095002/23095690
Website: http://www.phaarmasia.in
Email: phaarmasiagrd@gmail.com
12-10-167,
Progressive Towers, Bharath Nagar,
Hyderbad - 500018
Tel: 91-040-23818475/76/2
Website: www.vccilindia.com
Email: info@vccilindia.com
Summary
Incorporated in 1981, Phaarmasia Limited is a manufacturing unit dedicated in manufacturing facility of Hormonal (Oral contraceptive tablets) and Combipack with Iron Tablet. M/s Phaarmasia Limited Uni...
Read More
Reports by Phaarmasia Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.